Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure

B Andersson1, K Caidahl, F Waagstein

  • 1Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Sjukhuset, Goteborg University, Sweden.

European Heart Journal
|January 1, 1995
PubMed

Insights

Idiopathic dilated cardiomyopathy (IDCM) affects 29.2 per million people annually, with incidence rising with age. This study determined the true incidence and prevalence of IDCM in a defined population.

Area of Science:

  • Cardiology
  • Epidemiology

Background:

  • Idiopathic dilated cardiomyopathy (IDCM) is a diagnosis of exclusion with significant prognostic implications.
  • The current incidence and age distribution of IDCM in a well-defined population remain largely unknown.
  • Understanding IDCM epidemiology is crucial for resource allocation and treatment strategies.

Purpose of the Study:

  • To estimate the proportion of IDCM among congestive heart failure (CHF) patients.
  • To determine the age- and gender-standardized incidence rate of IDCM.
  • To evaluate the prognostic implications and prevalence of IDCM in a defined region.

Main Methods:

  • Retrospective analysis of 2711 patient records (16-65 years) hospitalized for CHF or IDCM over 6 years in Western Sweden.
  • Diagnostic investigation including echocardiography for 411 patients lacking an obvious etiology for CHF/IDCM.
  • Comparison of affected patients with a control group of 103 healthy individuals.

Main Results:

  • 27% of living CHF patients lacked an identifiable cause; 30% of these showed left ventricular dilatation and systolic dysfunction.
  • An age-gender standardized incidence rate of 29.2 cases per 10^6 persons/year for IDCM was established.
  • IDCM incidence increased with age and was higher in urban than rural areas (32 vs 21/10^6).

Conclusions:

  • The study provides crucial epidemiological data on IDCM incidence and prevalence.
  • IDCM's relative contribution to heart failure is greater in younger individuals.
  • Findings highlight the need for continued research into IDCM etiology and management.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...